Experiment summary for ENCSR701SED
doi:10.17989/ENCSR701SED
Summary
- Status
- released
- Assay
- ChIP-seq (TF ChIP-seq)
- Target
- OSR1
- Biosample summary
- Homo sapiens SK-N-SH genetically modified (insertion) using CRISPR targeting H. sapiens OSR1 treated with 6 μM all-trans-retinoic acid for 48 hours
- Biosample Type
- cell line
- Replication type
- isogenic
- Description
- eGFP-OSR1 ChIP-seq on human SK-N-SH
- Treatments
- 6 μM all-trans-retinoic acid (CHEBI:15367) for 48 hours
- Nucleic acid type
- DNA
- Size range
- 250-450
- Fragmentation methods
- sonication (Bioruptor Pico)
- Platform
- Illumina NovaSeq 6000
- Controls
Attribution
ENCODE4 project
- Lab
- Michael Snyder, Stanford
- Award
- UM1HG009442 (Michael Snyder, Stanford)
- Project
- ENCODE
- External resources
- Aliases
- michael-snyder:pCS-573, michael-snyder:pCS-eGFP-OSR1 SK-NSH (rep3) ChIP
- Date released
- May 18, 2022
- Tags
Isogenic replicates
Isogenic replicate | Technical replicate | Summary | Biosample | Modifications | Antibody | Library |
|---|---|---|---|---|---|---|
| 1 | 1 | Homo sapiens SK-N-SH cell line genetically modified (insertion) using CRISPR targeting H. sapiens OSR1 treated with 6 μM all-trans-retinoic acid for 48 hours | ENCBS678TES | ENCGM023VKT | ENCAB728YTO | ENCLB234RAO |
| 2 | 1 | Homo sapiens SK-N-SH cell line genetically modified (insertion) using CRISPR targeting H. sapiens OSR1 treated with 6 μM all-trans-retinoic acid for 48 hours | ENCBS242NBY | ENCGM023VKT | ENCAB728YTO | ENCLB882AJP |